Joy Ho
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
-
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
Papers in
-
- Multiple Myeloma Research and Treatments 9
-
- Protein Degradation and Inhibitors 5
- Co-authors
- John Gibson (8 shared papers)Douglas Joshua (5 shared papers)Christian Bryant (1 shared paper)Ross Brown (7 shared papers)Barbara Fazekas de St Groth (4 shared papers)Antony Basten (4 shared papers)Daniel Sze (3 shared papers)Maria Raitakari (2 shared papers)
- Journals
- Journal of Clinical Oncology (2 papers)Blood (2 papers)Clinical Infectious Diseases (1 paper)Bone Marrow Transplantation (1 paper)The Medical Journal of Australia (1 paper)
- Partner nations
- AustraliaNew ZealandUnited States
In The Last Decade
Joy Ho
14 papers receiving 321 citations
Peers
Comparison fields: 5 of 53
- Hematology 171
- Immunology 125
- Oncology 113
- Genetics 28
- Pathology and Forensic Medicine 29
Countries citing papers authored by Joy Ho
This map shows the geographic impact of Joy Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joy Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joy Ho more than expected).
Fields of papers citing papers by Joy Ho
This network shows the impact of papers produced by Joy Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joy Ho. The network helps show where Joy Ho may publish in the future.
Co-authors
The 25 scholars most cited alongside Joy Ho, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 105 | |
| 2 | 2019 | 89 | |
| 3 | 2003 | 26 | |
| 4 | 2018 | 25 | |
| 5 | 2016 | 22 | |
| 6 | 2015 | 11 | |
| 7 | 2015 | 11 | |
| 8 | 2021 | 9 | |
| 9 | 2003 | 7 | |
| 10 | 2005 | 5 | |
| 11 | 2019 | 5 | |
| 12 | 2003 | 4 | |
| 13 | 2017 | 3 | |
| 14 | 2023 | 1 |
About Joy Ho
Joy Ho is a scholar working on Hematology, Molecular Biology, Oncology, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 14 papers that have together received 323 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (9 papers), Protein Degradation and Inhibitors (5 papers), Peptidase Inhibition and Analysis (4 papers), Immunotherapy and Immune Responses (3 papers), CAR-T cell therapy research (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Cancer Treatment and Pharmacology (2 papers) and T-cell and B-cell Immunology (2 papers). The work is most often cited by research in Hematology (171 citations), Immunology (125 citations), Oncology (113 citations), Genetics (28 citations) and Pathology and Forensic Medicine (29 citations). Joy Ho has collaborated with scholars based in Australia, New Zealand and United States. Frequent co-authors include John Gibson, Douglas Joshua, Christian Bryant, Ross Brown, Barbara Fazekas de St Groth, Antony Basten, Daniel Sze, Maria Raitakari, Alan G. Baxter and Peter Mollee. Their work appears in journals such as Journal of Clinical Oncology, Blood, Clinical Infectious Diseases, Bone Marrow Transplantation and The Medical Journal of Australia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.